Display Shows:

My Language:

GRACEcast

Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.

Visit Show Website http://cancerGRACE.org/

Recently Aired


  • HD

    Who Benefits from Immunotherapy?

    Immunotherapy Forum Video #27: Immunotherapies work well in some, but ...

    Immunotherapy Forum Video #27: Immunotherapies work well in some, but not in others. Who benefits, and why? Dr. Sumanta (Monty) Pal explains what doctors are learning.

    Apr 6, 2015 Read more
  • HD

    Lung Cancer Immunotherapy Q&A

    Immunotherapy Forum Video #26: Drs. Jared Weiss and Matthew Hellmann ...

    Immunotherapy Forum Video #26: Drs. Jared Weiss and Matthew Hellmann answer questions from the audience following their presentations on immunotherapy for lung cancer. Moderated by Dr. Jack West.

    Apr 1, 2015 Read more
  • HD

    Benjamin Levy, MD, Hails 2015 as the Year of Lung Cancer Clinical Trials

    Thoracic oncologist Dr. Ben Levy highlights what he believes was ...

    Thoracic oncologist Dr. Ben Levy highlights what he believes was the biggest news for lung cancer patients in 2014 as well as his take on exciting clinical trials taking place in lung cancer in 2015.

    Mar 31, 2015 Read more
  • HD

    Immunotherapy for Lung Cancer: Currently Enrolling Clinical Trials of Combination Therapies

    Immunotherapy Forum Video #25: In Part 2 of 2 videos, ...

    Immunotherapy Forum Video #25: In Part 2 of 2 videos, Dr. Matthew Hellmann discusses currently enrolling clinical trials for lung cancer patients that study combination therapies (meaning an immunotherapy drug plus another drug is given).

    Mar 30, 2015 Read more
  • HD

    Currently Enrolling Clinical Trials of Single Agent Immunotherapies for Patients with Lung Cancer

    Immunotherapy Forum Video #24: In Part 1 of 2 videos, ...

    Immunotherapy Forum Video #24: In Part 1 of 2 videos, Dr. Matthew Hellmann provides an overview of clinical trials currently available to early and late stage lung cancer patients that study single agent immunotherapies (i.e. only one treatment is given).

    Mar 25, 2015 Read more
  • HD

    What We Know About Immunotherapy Treatments for Lung Cancer

    Immunotherapy Forum Video #23: Dr. Jared Weiss highlights what doctors ...

    Immunotherapy Forum Video #23: Dr. Jared Weiss highlights what doctors know about immunotherapy treatments for lung cancer. His words: "The pace of progress that I expect over the next 3 to 5 years will shock even the most optimistic..."

    Mar 23, 2015 Read more
  • HD

    Kidney Cancer Immunotherapy Q&A

    Immunotherapy Forum Video #22: Drs. Lauren Harshman and Sumanta (Monty) ...

    Immunotherapy Forum Video #22: Drs. Lauren Harshman and Sumanta (Monty) Pal answer questions from the audience following their presentations on immunotherapy for kidney cancer. Moderated by Dr. Marianne Davies.

    Mar 18, 2015 Read more
  • HD

    Kidney Cancer Immunotherapy: Reasons for Cautious Optimism

    Immunotherapy Forum Video #21: Dr. Sumanta (Monty) Pal reviews the ...

    Immunotherapy Forum Video #21: Dr. Sumanta (Monty) Pal reviews the past, present, and future of immunotherapy for kidney cancer and expresses concern about early study results of newer treatments.

    Mar 16, 2015 Read more
  • HD

    Kidney Cancer Immunotherapy: CTLA-4 & Vaccine Clinical Trials

    Immunotherapy Forum Video #20: Dr. Lauren Harshman talks about clinical ...

    Immunotherapy Forum Video #20: Dr. Lauren Harshman talks about clinical trials studying the CTLA-4 pathway, as well as vaccines.

    Mar 11, 2015 Read more
  • HD

    Kidney Cancer Immunotherapy: PD-1 Pathway Clinical Trials

    Immunotherapy Forum Video #19: Dr. Lauren Harshman discusses treating kidney ...

    Immunotherapy Forum Video #19: Dr. Lauren Harshman discusses treating kidney cancer with immunotherapy. In this video, she focuses on clinical trials studying PD-1 and PDL-1 agents.

    Mar 9, 2015 Read more
Loading...